Skip to content
lifestyle.hungrybear.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Elanco Animal Health
Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement
July 8, 2026
Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health
June 18, 2026
Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs
June 15, 2026
Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market
May 18, 2026
Elanco to Participate in Upcoming Investor Conferences
May 14, 2026
Elanco Animal Health Reports First Quarter 2026 Results
May 6, 2026
/C O R R E C T I O N — Elanco Animal Health/
April 28, 2026
Elanco’s Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock
April 27, 2026
←
Previous Page
1
2